US3640284A - Apparatus for electrotherapy of the pubococcygeus - Google Patents

Apparatus for electrotherapy of the pubococcygeus Download PDF

Info

Publication number
US3640284A
US3640284A US762A US3640284DA US3640284A US 3640284 A US3640284 A US 3640284A US 762 A US762 A US 762A US 3640284D A US3640284D A US 3640284DA US 3640284 A US3640284 A US 3640284A
Authority
US
United States
Prior art keywords
frequency
pubococcygeus
modulating
pulses
vaginal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US762A
Inventor
Philip A De Langis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of US3640284A publication Critical patent/US3640284A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/43Detecting, measuring or recording for evaluating the reproductive systems
    • A61B5/4306Detecting, measuring or recording for evaluating the reproductive systems for evaluating the female reproductive systems, e.g. gynaecological evaluations
    • A61B5/4318Evaluation of the lower reproductive system
    • A61B5/4337Evaluation of the lower reproductive system of the vagina
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/103Detecting, measuring or recording devices for testing the shape, pattern, colour, size or movement of the body or parts thereof, for diagnostic purposes
    • A61B5/107Measuring physical dimensions, e.g. size of the entire body or parts thereof
    • A61B5/1073Measuring volume, e.g. of limbs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61HPHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H21/00Massage devices for cavities of the body, e.g. nose, ears and anus ; Vibration or percussion related aspects A61H23/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/02Details
    • A61N1/04Electrodes
    • A61N1/05Electrodes for implantation or insertion into the body, e.g. heart electrode
    • A61N1/0521Genital electrodes
    • A61N1/0524Vaginal electrodes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/36007Applying electric currents by contact electrodes alternating or intermittent currents for stimulation of urogenital or gastrointestinal organs, e.g. for incontinence control

Definitions

  • ABSTRACT Apparatus for electrotherapy of the pubococcygeus muscle group of a female includes an electrode member contoured for insertion into the vagina. Spaced electrodes on the member are supplied with a carrier signal comprising shaped, bipolar pulses in the frequency range of from [51] int. Cl.
  • APPARATUS FOR ELECTROTIIERAPY OF THE PUBOCOCCYGEUS BACKGROUND OF THE INVENTION Primary muscular support for the female urogenital area is provided by two muscle groups, the iliococcygeus and the pubococcygeus. If the pubococcygeus muscles are atonic or functioning inadequately, a number of urogenital anomalies such as urinary stress incontinence and uterine prolapse may result. Moreover, poor functioning of the pubococcygeus muscles is a significant cause of female frigidity or sexual inadequacy.
  • Electrotherapy has been used extensively in the past to exercise muscles of various parts of the body in cases where natural muscle function has been lost or diminished. In such cases, the production of painless, graduated muscular exercise by electric stimulation reproduces the physical and chemical phenomenon connected with normal muscular work. But despite the widespread use of electrotherapy for other parts of the body, there have been virtually no reports of the application of such therapy to the female urogenital area.
  • the present electrotherapy apparatus includes electrical circuitry which provides a carrier signal comprising shaped bipolar pulses and having a carrier frequency in the range of from 20 Hz. to8 kHz., the signal being carrier modulated at a rate of between 0.2 Hz. and 10 Hz.
  • the bipolar pulses exercise striated muscles, and are shaped so that a relatively low-current initially is applied to the muscle, with a higher current being applied once the muscle has contracted.
  • the lowfrequency pulse modulation exercises smooth muscle and prevents continuous tetany.
  • the vaginometer comprises a generally cylindrical condom holder having a shank region over which the open end of a condom is stretched. An O-ring and an annular cover maintain the condom on the holder.
  • the condom portion of the vaginometer is inserted in the vagina and filled with water via an axial opening through the condom holder.
  • the vaginal volume may be measured by determining the amount of water required to fill the condom.
  • the pressure resulting from contraction of pubococcygeus muscles may be measured directly.
  • Another object of the present invention is to provide an electrotherapy apparatus including an electrode member contoured for insertion into the vagina, and means for supplying a programmed electrical signal to the electrode member for exercise of muscles in the pelvic region.
  • Yet another object of the present invention is to provide an apparatus for electrotherapy of the pubococcygeus muscle group and including means for exercising both striated and smooth muscle and for preventing continuous tetany.
  • Still another object of the present invention is to provide an apparatus for the electrotherapy of pubococcygeus muscles including means for applying a relatively low current to the muscles before they have contracted and a relatively larger current thereafter.
  • a further object of the present invention is to provide a novel vaginometer.
  • FIG. 1 is a perspective view of an electrode member contoured for insertion into the vagina, and useful as part of the inventive apparatus for electrotherapy of the pubococcygeus muscle group;
  • FIG. 2 is an electrical block diagram showing typical circuitry useful for providing a programmed electrical signal to the electrode member of FIG. 1;
  • FIG. 2a graphically illustrates a typical waveform produced by the circuitry of FIG. 2;
  • FIG. 3 is a perspective view of a novel condom-type vaginometer useful for measuring vaginal volume and vaginal pressure resulting from contraction of pubococcygeus muscles.
  • the apparatus comprises a generally tubular electrode member (FIG. 1) which is contoured for insertion into the vagina.
  • Member 10 includes a pair of Iongitudinally spaced, circumferential electrodes 11 and 12 to which is supplied a programmed electrical signal from the circuitry 13 of FIG. 2.
  • electrode member 10 includes a closed end 14 of generally hemispherical shape, and an open end 15 which is outwardly flared.
  • Member 10 preferably is constructed of plastic or other smooth, electrically nonconductive material. Electrodes l1 and 12 are flush with the exterior surface of member 10, and are positioned with electrode 11 adjacent end 14 and electrode 12 spaced approximately one-third of the way back toward end 15.
  • the interior 16 of tubular member 10 houses a pair of electrode wires 17 and 18 which are respectively connected to electrodes l1 and 12 interiorly thereof. Electrode wires 17 and 18 extend out through flared end 16, and are connected to the electrical circuitry of FIG. 2, as described below.
  • circuitry 13 includes an oscillator 20 having a frequency in the range of from 20 Hz. to 8 kHz., and preferably in the range of from 150 Hz. to 1 kHz.
  • Bipolar output pulses from oscillator 20 are shaped by a high-frequem cy signal processor 21, typically a passive filter network, which provides a gradual rise time to each pulse.
  • this shaping is desirable to provide initially low current to the striated muscles of the pubococcygeus, followed by a relatively higher current once these muscles have contracted.
  • the output of oscillator 20 also is shaped by a lowfrequency signal processor 22 which in effect introduces a low-frequency carrier modulation in the frequency range of from 0.2 to 10 Hz., and preferably in the range of from 0.5 to 1 Hz.
  • the shaped and modulated signals from processors 21 and 22 are combined in a conventional summing amplifier 23 to provide on a line 24 a carrier signal comprising shaped bipolar pulses and having a frequency in the range of from 20 Hz. to 8 kHz., the carrier signal being modulated at a low frequency in the range of from 0.2 to 10 Hz.
  • This signal on line 24 is amplified by an automatic gain control (AGC) amplifier 25 and by a power amplifier 26, and the amplified signal provided via a terminal 27 to one of electrodes 11 and 12 of member 10.
  • AGC automatic gain control
  • the other of electrodes 11 and 12 is connected to a temninal 28 associated with a constant current detector 29.
  • the average current flowing between electrodes 11 and 12 is sensed by constant current detector 29 which provides along a line 30 a signal indicative of the sensed current level.
  • the signal on line 30 is supplied to an automatic gain control (AGC) driver 31 which in turn controls the gain of AGC amplifier 25 in a manner so as to maintain the average current between electrodes 11 and 12 at a generally constant level.
  • a manual amplitude control 32 associated with AGC driver 31 permits operator selection of the average current level provided to electrode member 10. Preferably, average current levels below about 250 milliamperes may be employed.
  • a power supply 33 provides DC power to operate oscillator 20 and the other components of circuitry 13.
  • the circuitry of FIG. 2 is illustrative only, and other electronics may be used to produce the programmed electrical signal to electrode member 10.
  • the excitation signal provided to electrodes 11 and 12 should include both highfrequency and low-frequency components.
  • the pelvic area muscle group includes both striated and smooth muscle, both of which must be considered in any process of pelvic rehabilitation.
  • effective, painless vaginal muscle stimulation requires bipolar pulses of relatively high frequency (20 Hz. to 8 kHz.) to contract striatedmuscle and relatively low frequency (0.2 to l0 Hz.) bipolar pulses to contract the smooth muscle.
  • the optimum frequencies for these bipolar pulses vary somewhat from patient to patient, but generally are in the range of from Hz. to l kHz. for the high-frequency component and from 0.5 to l Hz. for the low-frequency component.
  • the low-frequency component may be introduced by carrier modulating a high-frequency signal comprising bipolar pulses.
  • the wave shape of the bipolar pulses comprising the relatively high-frequency component of the excitation signal to electrode member 10 is not critical. In fact, both sine wave and square wave signals have been found to work effectively. However, for optimum exercise of striated muscle, it is desirable that the pulses be shaped to provide an initially low current, followed by a considerably higher current as the muscle starts to contract. Similarly, the shape of the low-frequency carrier modulation is not critical. However, a relatively slow rise time again is desirable to provide an initially low current to the smooth muscles, followed by a higher current when these muscles begin to contract.
  • FIG. 2a shows a typical signal produces by the circuit of FIG. 2; the shape of the lowfrequency modulation is clearly evident. However, signals having waveshapes other than that illustrated in FIG. 2a may be used effectively with the inventive apparatus.
  • the low-frequency component of the excitation signal in addition to causing contraction of smooth muscle, also functions to avoid continuous tetany of the striated muscles. This is desirable, since if the striated muscle were continuously contracted by the high-frequency component, the muscle would tend to accommodate or relax, and little or no effective exercise of the striated muscle would result despite continued application of the bipolar pulses. By interrupting or modulating the high frequency carrier at a low-frequency rate, such continuous tetany is avoided, and the striated muscle has no chance to acconunodate or relax.
  • the shaping of the highand low-frequency signal compornents also serves the function of eliminating very highfrequency components (in excess of several thousand Hz.) which develop heat within the tissue and/or stimulate the pain receptors. This insures that the electrotherapy will be painless to the patient.
  • the low-frequency component allows use of the present apparatus on both innervated and denervated muscles.
  • electrode member 10 is inserted into the vagina of the patient, possibly using a lubricant such as water.
  • Electrode wires 17 and 18 are connected to terminals 27 and 28 of circuitry 13 (FIG. 2), and the manual amplitude control 32 is given to the patient.
  • the patient increases the amplitude of the excitation signal from circuitry 13 to a point where pubococcygeus muscle contractions occur. Because of accommodation, the patient typically will increase the amplitude of the excitation signal from time to time during the treatment. Optimum muscle exercise was found to occur when electrodes 11 and 12 were positioned over the motor points of the pubococcygeus.
  • Vaginometer of FIG. 3 This device permits measurement of the vaginal volume and also of the vaginal pressure resulting when the pubococcygeus muscles are contracted.
  • vaginomenter 40 comprises a generally cylindrical condom holder 41 having a vaginal shank region 42 of relatively small diameter and a flared body region 43 of relatively larger diameter.
  • An axial opening 44 extends through condom holder 41.
  • Attached rearwardly of condom holder 41 is a disc-shaped back plater 45 having a central opening 46.
  • Vaginometer 40 also includes an Oring 47 and an annular cover 48 of plastic, hard rubber or the like. The diameter of central opening 49 in cover 48 is slightly larger than the outer diameter of shank region 42 of condom holder 41.
  • vaginal orifice shank 42 is provided to assist in holding the vaginometer in the vagina, and to eliminate false pressure readings which might otherwise result should the patient contract the vaginal orifice.
  • condom 51 When vaginometer 40 is assembled as described, condom 51 may be filled with water or other fluid supplied underpressure from a syringe (not shown) via an inlet tube 530 (FIG. 3), a valve 54 and a tube 55 which communicate with the interior of condom 51 via axial openings 44 and 46.
  • a manometer (not shown) is connected for fluid communication with the interior of condom 51 via a line 56, valve 54 and tube 55.
  • Valve 54 permits selection of whether vaginometer 40 is connected to inlet tube 53, so as to permit filling of condom 51, or to line 56, so as to facilitate manometer measurement of vaginal pressure.
  • condom portion 51 of vaginometer 40 is inserted into the vagina with shank portion 42 of condom holder 41 extending into the vaginal orifice.
  • valve 54 positioned to provide fluid communication between tubes 53 and 55, condom 51 may be filled with warm water from a syringe (not shown).
  • the condom is unfused with water until a tare pressure of millimeters of mercury (mm. Hg.) is observed.
  • the patient then is asked to contract rapidly the vaginal and abdominal muscles.
  • the condom water pressure again is checked. If the vaginometer pressure has changed, more water is infused and the exercise repeated until a constant pressure is obtained. This insures complete vaginal filling.
  • the amount of water required 1 to fill condom 5 1 then is indicative of the vaginal volume.
  • vaginal pressure resulting from contraction of pubococcygeus muscles vaginometer is inserted in the vagina and filled with fluid as described above. The patient is asked to contract the vaginal muscles only, with the lungs empty. During the measurement, the abdomen may be palpated to ensure that the abdominal muscles are not contracting. To obtain the vaginal pressure reading, valve 54 is turned to provide fluid communication between the manometer line 56 and the interior of condom 51, via tube 55. Typically, the patient is asked to maintain this pubococcygeus contraction for about 10 seconds while a manometer pressure reading is taken.
  • the apparatus may also be used for the male or female as a rectal probe or electrode.
  • Apparatus for electrotherapy including, a pair of spaced electrodes; means developing a carrier wave which is substantially a sine wave having a frequency within the range of Hz. to 1 kHz., means amplitude modulating said carrier wave with a modulating signal having a frequency substantially less than said carrier frequency and producing a series of recurrent bipolar pulses with each of said pulses having a duration established by said modulating signal and consisting of varia tions in its amplitude at said carrier wave frequency from a maximum positive value, to a zero value to a maximum negative value, to a zero value to a maximum positive value, and so forth; and means connected to said amplitude modulating means and continuously modifying said maximum positive values and said maximum minimum values such that they become progressively larger at a slower rate during initial development of each of said pulses than during subsequent development such that each of said bipolar pulses is defined by a slowly rising portion followed by a portion of substantially constant amplitude; and means applying said bipolar pulses to said electrodes.
  • modulating frequency is in the range of 150 Hz. to 1 kHz.
  • Apparatus as defined in claim 1 including means for limiting the current flow to said electrodes to a value which does not exceed 250 milliamperes.

Abstract

Apparatus for electrotherapy of the pubococcygeus muscle group of a female. The apparatus includes an electrode member contoured for insertion into the vagina. Spaced electrodes on the member are supplied with a carrier signal comprising shaped, bipolar pulses in the frequency range of from 20 Hz. to 8 kHz., the signal being carrier modulated at a rate of between 0.2 Hz. and 10 Hz. The bipolar pulses exercise striated muscle, while the low-frequency modulation contracts smooth muscle and prevents continuous tetany. A condom-type vaginometer permits measurement of vaginal volume and of vaginal pressure resulting from contraction of pubococcygeus muscles.

Description

llnited States Patent De Langis [151 smmm 1 Feh.%,1972
[54] APPARATUS FOR ELECTROTHERAPY OF THE IPUBOCOCCYGEUS 21 Appl. No.: 762
[52] U.S.Cl. ..l28/422, 128/2 S, 128/408 3,056,409 10/1962 Edwards ..l28/422 Primary Examiner-Hugh R. Chamblee Attorney-Lyon & Lyon [5 7] ABSTRACT Apparatus for electrotherapy of the pubococcygeus muscle group of a female. The apparatus includes an electrode member contoured for insertion into the vagina. Spaced electrodes on the member are supplied with a carrier signal comprising shaped, bipolar pulses in the frequency range of from [51] int. Cl. ..A61n 01/06 20 to 8 KHZ, the Signal being carrier modulated at a r 58 Field of Search ..12s/2, 24.1,24.4, 407,408, of between and 10 The bipolar Pulses exercise 123/422 striated muscle, while the low-frequency modulation contracts smooth muscle and prevents continuous tetany. A condom- 56] Reiereuces Cited type vaginometer permits measurement of vaginal volume and of vaginal pressure resulting from contraction of pubococ- UNITED STATES PATENTS yg s mus le 3,403,684 10/1968 Stiebel et a1. 128/407 4 Claims, 4 Drawing Figures POWER 217 iii/f AMP 27 7'0 24 Z ELECT/Q0055 [0W I fiesagfgf 25 5/ flR06E'550/Q 28 .92
22 MIA/VAL 2p AMPL I7'UOE CUII/TROL ER 29 cgfr t in rs 3/ CONSTANT CURRENT 0575670/2 PATENTED rsa 81972 EHEET W W 2 INVENTOR.
APPARATUS FOR ELECTROTIIERAPY OF THE PUBOCOCCYGEUS BACKGROUND OF THE INVENTION Primary muscular support for the female urogenital area is provided by two muscle groups, the iliococcygeus and the pubococcygeus. If the pubococcygeus muscles are atonic or functioning inadequately, a number of urogenital anomalies such as urinary stress incontinence and uterine prolapse may result. Moreover, poor functioning of the pubococcygeus muscles is a significant cause of female frigidity or sexual inadequacy.
Proper adjustment to sexual relations by married persons is a significant element of happiness in marriage. Unsatisfactory adjustment can, and frequently does lead to unhappiness, to adverse affects on personality, and in many cases, to divorce. Therefore, it is important that married persons learn to perform their respective sexual roles as well as possible, and that physicians have the means available to assist them in doing so. To this end, awareness of the role played by the pubococcygeus muscles in female frigidity is of considerable importance.
In typical cases of apparent female frigidity, the strength of the pubococcygeus has been tested and the muscles found to be functioning at less than about percent of their optimum. In the past, gynecologists have treated this problem by perscribing a series of exercises to be performed by the female to tone up the pubococcygeus muscles. These exercises included voluntary contraction of the muscles in the midpelvic area, and particularly of the muscles surrounding the middle onethird of the vagina. The result of such exercise was a very marked improvement in sexual appreciation and response of the female. Often patients reported that they were feeling more sexually, and many indicated that they were experiencing vaginal orgasms for the first time in their lives.
Similar marked improvement in other urogenital anomalies have been reported as a result of exercise of the pubococcygeus muscle. For example, women who experience urinary incontinence found that after a program of exercise of the pubococcygeus muscle they were able to control bladder release to a degree not previously possible.
Electrotherapy has been used extensively in the past to exercise muscles of various parts of the body in cases where natural muscle function has been lost or diminished. In such cases, the production of painless, graduated muscular exercise by electric stimulation reproduces the physical and chemical phenomenon connected with normal muscular work. But despite the widespread use of electrotherapy for other parts of the body, there have been virtually no reports of the application of such therapy to the female urogenital area.
SUMMARY OFTI-IE INVENTION muscles. Use of the inventive apparatus results in significant improvement in the tone, strength and functioning of the pub'ococcygeus muscles. Benefits of such use including significant reduction in female frigidity, relief from urinary incontinence difiiculties and improvement of other urogenital anomalies.
The present electrotherapy apparatus includes electrical circuitry which provides a carrier signal comprising shaped bipolar pulses and having a carrier frequency in the range of from 20 Hz. to8 kHz., the signal being carrier modulated at a rate of between 0.2 Hz. and 10 Hz. The bipolar pulses exercise striated muscles, and are shaped so that a relatively low-current initially is applied to the muscle, with a higher current being applied once the muscle has contracted. The lowfrequency pulse modulation exercises smooth muscle and prevents continuous tetany.
To measure the condition and performance of the pubococcygeus muscle, there is also disclosed a novel condom-type vaginometer which permits measurement of the vaginal volume and of the pressure resulting from contraction of pubococcygeus muscles. The vaginometer comprises a generally cylindrical condom holder having a shank region over which the open end of a condom is stretched. An O-ring and an annular cover maintain the condom on the holder.
In use, the condom portion of the vaginometer is inserted in the vagina and filled with water via an axial opening through the condom holder. The vaginal volume may be measured by determining the amount of water required to fill the condom. By connecting a manometer to the vaginometer, the pressure resulting from contraction of pubococcygeus muscles may be measured directly.
Thus, it is an object of the present invention to provide apparatus for electrotherapy of the female pubococcygeus muscles.
Another object of the present invention is to provide an electrotherapy apparatus including an electrode member contoured for insertion into the vagina, and means for supplying a programmed electrical signal to the electrode member for exercise of muscles in the pelvic region.
It is another object of the present invention to provide an electrotherapy apparatus including circuitry to supply a carrier signal comprising shaped bipolar pulses of a relatively high frequency, the carrier signal being modulated at a relatively low frequency.
Yet another object of the present invention is to provide an apparatus for electrotherapy of the pubococcygeus muscle group and including means for exercising both striated and smooth muscle and for preventing continuous tetany.
Still another object of the present invention is to provide an apparatus for the electrotherapy of pubococcygeus muscles including means for applying a relatively low current to the muscles before they have contracted and a relatively larger current thereafter.
A further object of the present invention is to provide a novel vaginometer.
It is a further object of the present invention to provide a vaginometer of the condom-type, useful for measuring vaginal volume and vaginal pressure resulting from contraction of pubococcygeus muscles.
BRIEF DESCRIPTION OF THE DRAWINGS Still other objects, features and attendant advantages of the present invention will become apparent to those skilled in the art from a description of the preferred embodiments constructed in accordance herewith, taken in conjunction with the accompanying drawings, wherein like numerals designate like parts in the several figures, and wherein:
FIG. 1 is a perspective view of an electrode member contoured for insertion into the vagina, and useful as part of the inventive apparatus for electrotherapy of the pubococcygeus muscle group;
FIG. 2 is an electrical block diagram showing typical circuitry useful for providing a programmed electrical signal to the electrode member of FIG. 1;
FIG. 2a graphically illustrates a typical waveform produced by the circuitry of FIG. 2; and
FIG. 3 is a perspective view of a novel condom-type vaginometer useful for measuring vaginal volume and vaginal pressure resulting from contraction of pubococcygeus muscles.
DESCRIPTION OF THE PREFERRED EMBODIMENTS Referring now to tlne drawings, and particularly to FIGS. 1 and 2 thereof, there is shown a preferred embodiment of the inventive apparatus for electrotherapy of the pubococcygeus muscle group. In general, the apparatus comprises a generally tubular electrode member (FIG. 1) which is contoured for insertion into the vagina. Member 10 includes a pair of Iongitudinally spaced, circumferential electrodes 11 and 12 to which is supplied a programmed electrical signal from the circuitry 13 of FIG. 2.
Referring in greater detail to FIG. 1, electrode member 10 includes a closed end 14 of generally hemispherical shape, and an open end 15 which is outwardly flared. Member 10 preferably is constructed of plastic or other smooth, electrically nonconductive material. Electrodes l1 and 12 are flush with the exterior surface of member 10, and are positioned with electrode 11 adjacent end 14 and electrode 12 spaced approximately one-third of the way back toward end 15. The interior 16 of tubular member 10 houses a pair of electrode wires 17 and 18 which are respectively connected to electrodes l1 and 12 interiorly thereof. Electrode wires 17 and 18 extend out through flared end 16, and are connected to the electrical circuitry of FIG. 2, as described below.
For effective electrotherapy of the pubococcygeus muscle group, it is desirable to supply to electrodes 11 and 12 a signal having both high-frequency and low-frequency components. Illustrative circuitry for providing such a signal is shown in FIG. 2. Referring thereto, circuitry 13 includes an oscillator 20 having a frequency in the range of from 20 Hz. to 8 kHz., and preferably in the range of from 150 Hz. to 1 kHz. Bipolar output pulses from oscillator 20 are shaped by a high-frequem cy signal processor 21, typically a passive filter network, which provides a gradual rise time to each pulse. As will be described below, this shaping is desirable to provide initially low current to the striated muscles of the pubococcygeus, followed by a relatively higher current once these muscles have contracted. The output of oscillator 20 also is shaped by a lowfrequency signal processor 22 which in effect introduces a low-frequency carrier modulation in the frequency range of from 0.2 to 10 Hz., and preferably in the range of from 0.5 to 1 Hz.
The shaped and modulated signals from processors 21 and 22 are combined in a conventional summing amplifier 23 to provide on a line 24 a carrier signal comprising shaped bipolar pulses and having a frequency in the range of from 20 Hz. to 8 kHz., the carrier signal being modulated at a low frequency in the range of from 0.2 to 10 Hz. This signal on line 24 is amplified by an automatic gain control (AGC) amplifier 25 and by a power amplifier 26, and the amplified signal provided via a terminal 27 to one of electrodes 11 and 12 of member 10. The other of electrodes 11 and 12 is connected to a temninal 28 associated with a constant current detector 29.
The average current flowing between electrodes 11 and 12 is sensed by constant current detector 29 which provides along a line 30 a signal indicative of the sensed current level. The signal on line 30 is supplied to an automatic gain control (AGC) driver 31 which in turn controls the gain of AGC amplifier 25 in a manner so as to maintain the average current between electrodes 11 and 12 at a generally constant level. A manual amplitude control 32 associated with AGC driver 31 permits operator selection of the average current level provided to electrode member 10. Preferably, average current levels below about 250 milliamperes may be employed. A power supply 33 provides DC power to operate oscillator 20 and the other components of circuitry 13.
The circuitry of FIG. 2 is illustrative only, and other electronics may be used to produce the programmed electrical signal to electrode member 10. However, the excitation signal provided to electrodes 11 and 12 should include both highfrequency and low-frequency components. The reason for this is that the pelvic area muscle group includes both striated and smooth muscle, both of which must be considered in any process of pelvic rehabilitation. Experiments have proved that effective, painless vaginal muscle stimulation requires bipolar pulses of relatively high frequency (20 Hz. to 8 kHz.) to contract striatedmuscle and relatively low frequency (0.2 to l0 Hz.) bipolar pulses to contract the smooth muscle. The optimum frequencies for these bipolar pulses vary somewhat from patient to patient, but generally are in the range of from Hz. to l kHz. for the high-frequency component and from 0.5 to l Hz. for the low-frequency component. As mentioned hereinabove, the low-frequency component may be introduced by carrier modulating a high-frequency signal comprising bipolar pulses.
The wave shape of the bipolar pulses comprising the relatively high-frequency component of the excitation signal to electrode member 10 is not critical. In fact, both sine wave and square wave signals have been found to work effectively. However, for optimum exercise of striated muscle, it is desirable that the pulses be shaped to provide an initially low current, followed by a considerably higher current as the muscle starts to contract. Similarly, the shape of the low-frequency carrier modulation is not critical. However, a relatively slow rise time again is desirable to provide an initially low current to the smooth muscles, followed by a higher current when these muscles begin to contract. FIG. 2a shows a typical signal produces by the circuit of FIG. 2; the shape of the lowfrequency modulation is clearly evident. However, signals having waveshapes other than that illustrated in FIG. 2a may be used effectively with the inventive apparatus.
The low-frequency component of the excitation signal, in addition to causing contraction of smooth muscle, also functions to avoid continuous tetany of the striated muscles. This is desirable, since if the striated muscle were continuously contracted by the high-frequency component, the muscle would tend to accommodate or relax, and little or no effective exercise of the striated muscle would result despite continued application of the bipolar pulses. By interrupting or modulating the high frequency carrier at a low-frequency rate, such continuous tetany is avoided, and the striated muscle has no chance to acconunodate or relax.
The shaping of the highand low-frequency signal compornents also serves the function of eliminating very highfrequency components (in excess of several thousand Hz.) which develop heat within the tissue and/or stimulate the pain receptors. This insures that the electrotherapy will be painless to the patient. Moreover, the low-frequency component allows use of the present apparatus on both innervated and denervated muscles.
In operation, electrode member 10 is inserted into the vagina of the patient, possibly using a lubricant such as water. Electrode wires 17 and 18 are connected to terminals 27 and 28 of circuitry 13 (FIG. 2), and the manual amplitude control 32 is given to the patient. The patient increases the amplitude of the excitation signal from circuitry 13 to a point where pubococcygeus muscle contractions occur. Because of accommodation, the patient typically will increase the amplitude of the excitation signal from time to time during the treatment. Optimum muscle exercise was found to occur when electrodes 11 and 12 were positioned over the motor points of the pubococcygeus.
Significant improvement in the tone, strength and functioning of the pubococcygeus muscle group was found to result from regular use of the inventive electrotherapy apparatus. To facilitate actual quantitative measurement of this improvement, the Vaginometer of FIG. 3 was developed. This device permits measurement of the vaginal volume and also of the vaginal pressure resulting when the pubococcygeus muscles are contracted.
Referring to FIG. 3, vaginomenter 40 comprises a generally cylindrical condom holder 41 having a vaginal shank region 42 of relatively small diameter and a flared body region 43 of relatively larger diameter. An axial opening 44 extends through condom holder 41. Attached rearwardly of condom holder 41 is a disc-shaped back plater 45 having a central opening 46. Vaginometer 40 also includes an Oring 47 and an annular cover 48 of plastic, hard rubber or the like. The diameter of central opening 49 in cover 48 is slightly larger than the outer diameter of shank region 42 of condom holder 41.
weeks is indicated for each patient, as well as the total number of treatments. Typically, individual treatments were of about one-half hour in duration. The vaginal volume and vaginal pressure resulting from contraction of pubococcygeus muscles As illustrated in FIG. 3, the band 50 of a condom 51 is 5 prior to the treatment period isindicated, and the correspondstretched over shank region 42 of holder 41, and the condom ing vaginal volume and pressure values measured at the end of threaded thro gh O-rmg 47 and ann lar cover 48 The O-rmg the treatment period also are listed. Note that as a control, 47 and cover 48 are Posmoned about Shank 8 42 to Table 1 includes data for two patients (Case Nos. 6 and 7) secure the condom open end 52 to holder 41. Cover 48 h i d no t t nt,
TABLE I Pre-treatment Post-treatment Period of Patient treatment, Number of Volume, Vaginal Volumev Vaginal case no. (weeks) treatments (1111.) pressure (mL) prcssult 16 22 130 5 125 11s 12 35 150 0 140 110 s 150 *is 150 140 4 11 280 3 2x5 17 3. 5 10 150 *3 1511 *50 4 0 160 4 11m 5 4 0 150 *5 155 *5 *Cornbined vaginal and abdominal pressure.
prevents condom 51 from forming an aneurism outside the vagina which would give erroneous pressure and volume readings. Further, the vaginal orifice shank 42 is provided to assist in holding the vaginometer in the vagina, and to eliminate false pressure readings which might otherwise result should the patient contract the vaginal orifice.
When vaginometer 40 is assembled as described, condom 51 may be filled with water or other fluid supplied underpressure from a syringe (not shown) via an inlet tube 530 (FIG. 3), a valve 54 and a tube 55 which communicate with the interior of condom 51 via axial openings 44 and 46. For pressure measurement, a manometer (not shown) is connected for fluid communication with the interior of condom 51 via a line 56, valve 54 and tube 55. Valve 54 permits selection of whether vaginometer 40 is connected to inlet tube 53, so as to permit filling of condom 51, or to line 56, so as to facilitate manometer measurement of vaginal pressure.
In operation, the condom portion 51 of vaginometer 40 is inserted into the vagina with shank portion 42 of condom holder 41 extending into the vaginal orifice. With valve 54 positioned to provide fluid communication between tubes 53 and 55, condom 51 may be filled with warm water from a syringe (not shown). Typically, the condom is unfused with water until a tare pressure of millimeters of mercury (mm. Hg.) is observed. The patient then is asked to contract rapidly the vaginal and abdominal muscles. When this exercise is stopped, the condom water pressure again is checked. If the vaginometer pressure has changed, more water is infused and the exercise repeated until a constant pressure is obtained. This insures complete vaginal filling. The amount of water required 1 to fill condom 5 1 then is indicative of the vaginal volume.
To determine vaginal pressure resulting from contraction of pubococcygeus muscles, vaginometer is inserted in the vagina and filled with fluid as described above. The patient is asked to contract the vaginal muscles only, with the lungs empty. During the measurement, the abdomen may be palpated to ensure that the abdominal muscles are not contracting. To obtain the vaginal pressure reading, valve 54 is turned to provide fluid communication between the manometer line 56 and the interior of condom 51, via tube 55. Typically, the patient is asked to maintain this pubococcygeus contraction for about 10 seconds while a manometer pressure reading is taken.
The significant improvement is muscle tone, strength and functioning of the pubococcygeus resulting from treatment with the inventive electrotherapy apparatus is illustrated by the statistics in the following Table ll, derived from actual paticnt case histories. In this table, the period of treatment in As is evident from Table l, in each case, a very significant increase in vaginal pressure resulted at the end of the treatment period. This increase in pressure is indicative of the improved pubococcygeus muscle tone, strength and functioning resulting from use of the inventive apparatus. Typically, patients noted a significant increase in sexual interest and activity after treatment with the inventive electrotherapy apparatus. Moreover, in cases of urinary incontinence and other female urogenital anomalies, definite improvements also resulted when the pubococcygeus muscles were exercised and toned up by use of the apparatus described herein.
Although reference is made herein for use of the apparatus in connection with the vagina of a female, it is to be understood that the apparatus may also be used for the male or female as a rectal probe or electrode.
While the invention has been described with respect to several physical embodiments constructed in accordance therewith, it will be apparent to those skilled in the art that various modifications and improvements may be made without departing from the scope and spirit of the invention.
I claim:
1. Apparatus for electrotherapy including, a pair of spaced electrodes; means developing a carrier wave which is substantially a sine wave having a frequency within the range of Hz. to 1 kHz., means amplitude modulating said carrier wave with a modulating signal having a frequency substantially less than said carrier frequency and producing a series of recurrent bipolar pulses with each of said pulses having a duration established by said modulating signal and consisting of varia tions in its amplitude at said carrier wave frequency from a maximum positive value, to a zero value to a maximum negative value, to a zero value to a maximum positive value, and so forth; and means connected to said amplitude modulating means and continuously modifying said maximum positive values and said maximum minimum values such that they become progressively larger at a slower rate during initial development of each of said pulses than during subsequent development such that each of said bipolar pulses is defined by a slowly rising portion followed by a portion of substantially constant amplitude; and means applying said bipolar pulses to said electrodes.
2. Apparatus as set forth in claim 1 in which modulating frequency is in the range of 150 Hz. to 1 kHz.
3. Apparatus as set forth i claim 1 in which said modulating frequency is within the range of 0.5 Hz. to 1 kHz.
4. Apparatus as defined in claim 1 including means for limiting the current flow to said electrodes to a value which does not exceed 250 milliamperes.
* w n t n

Claims (4)

1. Apparatus for electrotherapy including, a pair of spaced electrodes; means developing a carrier wave which is substantially a sine wave having a frequency within the range of 150 Hz. to 1 kHz., means amplitude modulating said carrier wave with a modulating signal having a frequency substantially less than said carrier frequency and producing a series of recurrent bipolar pulses with each of said pulses having a duration established by said modulating signal and consisting of variations in its amplitude at said carrier wave frequency from a maximum positive value, to a zero value to a maximum negative value, to a zero value to a maximum positive value, and so forth; and means connected to said amplitude modulating means and continuously modifying said maximum positive values and said maximum minimum values such that they become progressively larger at a slower rate during initial development of each of said pulses than during subsequent development such that each of said bipolar pulses is defined by a slowly rising portion followed by a portion of substantially constant amplitude; and means applying said bipolar pulses to said electrodes.
2. Apparatus as set forth in claim 1 in which modulating frequency is in the range of 150 Hz. to 1 kHz.
3. Apparatus as set forth in claim 1 in which said modulating frequency is within the range of 0.5 Hz. to 1 kHz.
4. Apparatus as defined in claim 1 including means for limiting the current flow to said electrodes to a value which does not exceed 250 milliamperes.
US762A 1970-01-05 1970-01-05 Apparatus for electrotherapy of the pubococcygeus Expired - Lifetime US3640284A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US76270A 1970-01-05 1970-01-05

Publications (1)

Publication Number Publication Date
US3640284A true US3640284A (en) 1972-02-08

Family

ID=21692922

Family Applications (1)

Application Number Title Priority Date Filing Date
US762A Expired - Lifetime US3640284A (en) 1970-01-05 1970-01-05 Apparatus for electrotherapy of the pubococcygeus

Country Status (1)

Country Link
US (1) US3640284A (en)

Cited By (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3933147A (en) * 1970-04-02 1976-01-20 Vall Wilbur E Du Apparatus and method for treating disorders in the region of the pubococcygeous muscle
US3941136A (en) * 1973-11-21 1976-03-02 Neuronyx Corporation Method for artificially inducing urination, defecation, or sexual excitation
DE2538369A1 (en) * 1974-08-29 1976-03-11 Gorenje Tovarna Gospodinjske CIRCUIT ARRANGEMENT FOR AN AUTOMATIC INTEGRATED INTRAVAGINAL STIMULATOR
US4050449A (en) * 1976-02-25 1977-09-27 Medical Products Development Corporation Apparatus for exercising muscles of a female patient's pelvic diaphragm
US4106511A (en) * 1976-04-21 1978-08-15 Svenska Utvecklingsaktiebolaget Electrical stimulator in remedy of incontinence
US4305402A (en) * 1979-06-29 1981-12-15 Katims Jefferson J Method for transcutaneous electrical stimulation
US4396019A (en) * 1978-03-06 1983-08-02 Perry Jr John D Vaginal myograph method and apparatus
US4476880A (en) * 1982-12-03 1984-10-16 Giem David A Apparatus for sensing and indicating vaginal muscle contraction
US4503863A (en) * 1979-06-29 1985-03-12 Katims Jefferson J Method and apparatus for transcutaneous electrical stimulation
US4537195A (en) * 1980-11-20 1985-08-27 Mcdonnell Roy E Electrical control of body discharges and headaches
US4550733A (en) * 1984-01-09 1985-11-05 Pain Suppression Labs, Inc. Electronic dental analgesia apparatus and methodology
US4559948A (en) * 1984-01-09 1985-12-24 Pain Suppression Labs Cerebral palsy treatment apparatus and methodology
DE3515691A1 (en) * 1985-05-02 1986-02-27 Günter 2071 Siek Straten Sucking-thrusting massage device (for the genital region)
US4574808A (en) * 1984-01-09 1986-03-11 Pain Suppression Labs, Inc. Apparatus and method for relieving symptoms of multiple sclerosis
US4586509A (en) * 1984-01-09 1986-05-06 Pain Suppression Labs, Inc. Temporomandibular joint-myofascial pain dysfunction syndrome treatment apparatus and methodology
WO1986002567A1 (en) * 1984-10-23 1986-05-09 Zion Foundation Method and apparatus for delivering a prescriptive electrical signal
US4614193A (en) * 1984-01-09 1986-09-30 Pain Suppression Labs, Inc. Electronic glaucoma treatment apparatus and methodology
US4627438A (en) * 1984-01-09 1986-12-09 Pain Suppression Labs, Inc. Electronic migraine modulator apparatus and methodology
US4688575A (en) * 1982-03-12 1987-08-25 Duvall Wilbur E Muscle contraction stimulation
US4784142A (en) * 1984-01-09 1988-11-15 Pain Suppression Labs, Inc. Methodology for electronic dental analgesia
US4844075A (en) * 1984-01-09 1989-07-04 Pain Suppression Labs, Inc. Transcranial stimulation for the treatment of cerebral palsy
DE3827232A1 (en) * 1988-04-26 1989-11-09 Shafik Dr Med Barsom Electric stimulator for treating female incontinence
US5107835A (en) * 1989-05-22 1992-04-28 Physiodynamics Electrotherapeutic treatment
US5109848A (en) * 1989-05-22 1992-05-05 Physiodynamics, Inc. Electrotherapeutic apparatus
WO1992007617A1 (en) * 1990-11-05 1992-05-14 Physiodynamics, Inc. Apparatus and method for electrotherapeutic eye treatment
WO1993024176A1 (en) * 1992-05-23 1993-12-09 Keith Edward Tippey Electrical stimulation for treatment of incontinence and other neuro-muscular disorders
WO1994015667A1 (en) * 1993-01-11 1994-07-21 Brent Carman Method of varying appropriate muscle strength of a person to alleviate urinary or fecal urgency or incontinence or vaginal or bladder spasms
US5433219A (en) * 1992-09-23 1995-07-18 Spery; Nanette S. Receptive condom assembly
US5674238A (en) * 1994-05-16 1997-10-07 Research Foundation Of The State Univ. Of N.Y. Perineometer
FR2762983A1 (en) * 1997-05-09 1998-11-13 Pascal Blondelle Vaginal or anal endo=cavity probe
WO2000019940A1 (en) * 1998-10-06 2000-04-13 Bio Control Medical, Ltd. Incontinence treatment device
WO2000019939A1 (en) * 1998-10-06 2000-04-13 Bio Control Medical, Ltd. Control of urge incontinence
NL1016228C2 (en) * 2000-09-21 2002-03-22 Best Medical Internat Beheer B Electro-stimulator for the treatment of incontinence.
US20030082884A1 (en) * 2001-10-26 2003-05-01 International Business Machine Corporation And Kabushiki Kaisha Toshiba Method of forming low-leakage dielectric layer
WO2003057313A1 (en) * 2002-01-02 2003-07-17 Ardent Pharmaceuticals, Inc. Method for screening therapeutic agents for modulation of ejaculatory response
US6712772B2 (en) 2001-11-29 2004-03-30 Biocontrol Medical Ltd. Low power consumption implantable pressure sensor
GB2404339A (en) * 2003-07-31 2005-02-02 Catherine Taylor Pelvic floor stimulation device
US6862480B2 (en) 2001-11-29 2005-03-01 Biocontrol Medical Ltd. Pelvic disorder treatment device
US20050107848A1 (en) * 2003-11-13 2005-05-19 Physiomed Elektromedizin Ag Apparatus for electrotherapy
US20050216069A1 (en) * 2001-11-29 2005-09-29 Biocontrol Medical Ltd. Pelvic disorder treatment device
US7079882B1 (en) 2000-01-22 2006-07-18 Richard Schmidt Method and apparatus for quantifying nerve and neural-muscular integrity related to pelvic organs or pelvic floor functions
WO2007059989A2 (en) * 2005-11-24 2007-05-31 Femeda Limited Self contained device with treatment cycle for electrostimulation
US20070260288A1 (en) * 2006-03-03 2007-11-08 Yossi Gross Apparatus for treating stress and urge incontinence
US20070265675A1 (en) * 2006-05-09 2007-11-15 Ams Research Corporation Testing Efficacy of Therapeutic Mechanical or Electrical Nerve or Muscle Stimulation
FR2902346A1 (en) * 2006-06-20 2007-12-21 Jean Luc Gonfard Neuromuscular system`s electrical stimulation device for female reproductive system, has electrodes fixed on support whose shape is adapted to anatomic cavity, where support has alveolus situated at specific place of area to be stimulated
US20080009914A1 (en) * 2006-07-10 2008-01-10 Ams Research Corporation Systems and Methods for Implanting Tissue Stimulation Electrodes in the Pelvic Region
US20090012592A1 (en) * 2006-07-10 2009-01-08 Ams Research Corporation Tissue anchor
US20090157091A1 (en) * 2006-04-04 2009-06-18 Ams Research Corporation Apparatus for Implanting Neural Stimulation Leads
US20090228067A1 (en) * 2005-11-24 2009-09-10 Femeda Ltd Compressible device
US20090228064A1 (en) * 2005-11-24 2009-09-10 Femeda Ltd Compressible electrodes
US20090270963A1 (en) * 2006-05-23 2009-10-29 Publiekrechtelijke Rechtspersoon Academisch Ziekenhuis Leiden H.O.D.N. Leids Universitair Medi Medical probe
US20100049289A1 (en) * 2007-07-10 2010-02-25 Ams Research Corporation Tissue anchor
US20100076254A1 (en) * 2006-06-05 2010-03-25 Ams Research Corporation Electrical muscle stimulation to treat fecal incontinence and/or pelvic prolapse
US20100217340A1 (en) * 2009-02-23 2010-08-26 Ams Research Corporation Implantable Medical Device Connector System
US20110082524A1 (en) * 2009-10-05 2011-04-07 Arp Manufacturing Llc Electro-Therapeutic Stimulator
US20110160793A1 (en) * 2009-12-31 2011-06-30 Ams Research Corporation Multi-Zone Stimulation Implant System and Method
US9119963B1 (en) 2014-12-11 2015-09-01 Mohammad Ali Al-Shemmeri Electric device for producing successive positive and negative electric charges
US9211211B2 (en) 2010-02-02 2015-12-15 Neil Luke Maurette Female posterior wall prosthesis
US9220887B2 (en) 2011-06-09 2015-12-29 Astora Women's Health LLC Electrode lead including a deployable tissue anchor
US9427573B2 (en) 2007-07-10 2016-08-30 Astora Women's Health, Llc Deployable electrode lead anchor
US9526892B2 (en) 2009-10-05 2016-12-27 ARP Wave LLC Electro-therapeutic stimulation
US9539433B1 (en) 2009-03-18 2017-01-10 Astora Women's Health, Llc Electrode implantation in a pelvic floor muscular structure
US9731112B2 (en) 2011-09-08 2017-08-15 Paul J. Gindele Implantable electrode assembly
US20180050201A1 (en) * 2016-08-17 2018-02-22 Pui Ling TAM Non-invasive device and method for stimulating vulvar tissues and pelvic floor muscles for treating and improving dysfunction or disorders and probe unit used therefor
US10105531B2 (en) 2015-09-07 2018-10-23 Femeda Ltd. Device for electrostimulation
US11110269B2 (en) 2014-08-19 2021-09-07 Femeda Ltd. Electrostimulation related devices and methods

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3056409A (en) * 1953-08-28 1962-10-02 Meryl J Edwards Method of and means for physiotherapy
US3403684A (en) * 1964-11-23 1968-10-01 Ariel I. Stiebel Electrical stimulator

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3056409A (en) * 1953-08-28 1962-10-02 Meryl J Edwards Method of and means for physiotherapy
US3403684A (en) * 1964-11-23 1968-10-01 Ariel I. Stiebel Electrical stimulator

Cited By (104)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3933147A (en) * 1970-04-02 1976-01-20 Vall Wilbur E Du Apparatus and method for treating disorders in the region of the pubococcygeous muscle
US3941136A (en) * 1973-11-21 1976-03-02 Neuronyx Corporation Method for artificially inducing urination, defecation, or sexual excitation
DE2538369A1 (en) * 1974-08-29 1976-03-11 Gorenje Tovarna Gospodinjske CIRCUIT ARRANGEMENT FOR AN AUTOMATIC INTEGRATED INTRAVAGINAL STIMULATOR
US4050449A (en) * 1976-02-25 1977-09-27 Medical Products Development Corporation Apparatus for exercising muscles of a female patient's pelvic diaphragm
US4106511A (en) * 1976-04-21 1978-08-15 Svenska Utvecklingsaktiebolaget Electrical stimulator in remedy of incontinence
US4396019A (en) * 1978-03-06 1983-08-02 Perry Jr John D Vaginal myograph method and apparatus
US4305402A (en) * 1979-06-29 1981-12-15 Katims Jefferson J Method for transcutaneous electrical stimulation
US4503863A (en) * 1979-06-29 1985-03-12 Katims Jefferson J Method and apparatus for transcutaneous electrical stimulation
US4537195A (en) * 1980-11-20 1985-08-27 Mcdonnell Roy E Electrical control of body discharges and headaches
US4688575A (en) * 1982-03-12 1987-08-25 Duvall Wilbur E Muscle contraction stimulation
US4476880A (en) * 1982-12-03 1984-10-16 Giem David A Apparatus for sensing and indicating vaginal muscle contraction
US4586509A (en) * 1984-01-09 1986-05-06 Pain Suppression Labs, Inc. Temporomandibular joint-myofascial pain dysfunction syndrome treatment apparatus and methodology
US4844075A (en) * 1984-01-09 1989-07-04 Pain Suppression Labs, Inc. Transcranial stimulation for the treatment of cerebral palsy
US4574808A (en) * 1984-01-09 1986-03-11 Pain Suppression Labs, Inc. Apparatus and method for relieving symptoms of multiple sclerosis
US4550733A (en) * 1984-01-09 1985-11-05 Pain Suppression Labs, Inc. Electronic dental analgesia apparatus and methodology
US4784142A (en) * 1984-01-09 1988-11-15 Pain Suppression Labs, Inc. Methodology for electronic dental analgesia
US4614193A (en) * 1984-01-09 1986-09-30 Pain Suppression Labs, Inc. Electronic glaucoma treatment apparatus and methodology
US4627438A (en) * 1984-01-09 1986-12-09 Pain Suppression Labs, Inc. Electronic migraine modulator apparatus and methodology
US4559948A (en) * 1984-01-09 1985-12-24 Pain Suppression Labs Cerebral palsy treatment apparatus and methodology
WO1986002567A1 (en) * 1984-10-23 1986-05-09 Zion Foundation Method and apparatus for delivering a prescriptive electrical signal
DE3515691A1 (en) * 1985-05-02 1986-02-27 Günter 2071 Siek Straten Sucking-thrusting massage device (for the genital region)
DE3827232A1 (en) * 1988-04-26 1989-11-09 Shafik Dr Med Barsom Electric stimulator for treating female incontinence
US5107835A (en) * 1989-05-22 1992-04-28 Physiodynamics Electrotherapeutic treatment
US5109848A (en) * 1989-05-22 1992-05-05 Physiodynamics, Inc. Electrotherapeutic apparatus
WO1992007617A1 (en) * 1990-11-05 1992-05-14 Physiodynamics, Inc. Apparatus and method for electrotherapeutic eye treatment
WO1993024176A1 (en) * 1992-05-23 1993-12-09 Keith Edward Tippey Electrical stimulation for treatment of incontinence and other neuro-muscular disorders
GB2269750A (en) * 1992-05-23 1994-02-23 Keith Edward Tippey Treatment of incontinence by electrical stimulation.
GB2269750B (en) * 1992-05-23 1997-01-08 Keith Edward Tippey Electrical stimulation for treatment of incontinence and other neuro-muscular disorders
US5433219A (en) * 1992-09-23 1995-07-18 Spery; Nanette S. Receptive condom assembly
GB2289626A (en) * 1993-01-11 1995-11-29 Brent Carman Method of varying appropiate muscle strength of a person to alleviate urinary or fecal urgency or incontinence or vaginal or bladder spasms
GB2289626B (en) * 1993-01-11 1996-08-28 Brent Carman Method of measuring and/or assessing appropriate muscle strength of a person to alleviate urinary or fecal urgency or incontinence or vaginal or bladder spasm
WO1994015667A1 (en) * 1993-01-11 1994-07-21 Brent Carman Method of varying appropriate muscle strength of a person to alleviate urinary or fecal urgency or incontinence or vaginal or bladder spasms
US5674238A (en) * 1994-05-16 1997-10-07 Research Foundation Of The State Univ. Of N.Y. Perineometer
FR2762983A1 (en) * 1997-05-09 1998-11-13 Pascal Blondelle Vaginal or anal endo=cavity probe
US7387603B2 (en) * 1998-10-06 2008-06-17 Ams Research Corporation Incontinence treatment device
WO2000019939A1 (en) * 1998-10-06 2000-04-13 Bio Control Medical, Ltd. Control of urge incontinence
US6354991B1 (en) 1998-10-06 2002-03-12 Bio Control Medical Ltd Incontinence treatment device
WO2000019940A1 (en) * 1998-10-06 2000-04-13 Bio Control Medical, Ltd. Incontinence treatment device
US6896651B2 (en) 1998-10-06 2005-05-24 Biocontrol Medical Ltd. Mechanical and electrical sensing for incontinence treatment
US7582053B2 (en) 1998-10-06 2009-09-01 Ams Research Corporation Control of urge incontinence
US8083663B2 (en) 1998-10-06 2011-12-27 Ams Research Corporation Pelvic disorder treatment
US6652449B1 (en) 1998-10-06 2003-11-25 Bio Control Medical, Ltd. Control of urge incontinence
US8340786B2 (en) 1998-10-06 2012-12-25 Ams Research Corporation Incontinence treatment device
US20080242918A1 (en) * 1998-10-06 2008-10-02 Ams Research Corporation Incontinence Treatment Device
US20050261746A1 (en) * 1998-10-06 2005-11-24 Yossi Gross Control of urge incontinence
US20050113881A1 (en) * 1998-10-06 2005-05-26 Yossi Gross Incontinence treatment device
US7079882B1 (en) 2000-01-22 2006-07-18 Richard Schmidt Method and apparatus for quantifying nerve and neural-muscular integrity related to pelvic organs or pelvic floor functions
NL1016228C2 (en) * 2000-09-21 2002-03-22 Best Medical Internat Beheer B Electro-stimulator for the treatment of incontinence.
WO2002034328A1 (en) * 2000-09-21 2002-05-02 Best Medical International Beheer B.V. Probe for treatment of incontinence
US20030082884A1 (en) * 2001-10-26 2003-05-01 International Business Machine Corporation And Kabushiki Kaisha Toshiba Method of forming low-leakage dielectric layer
US20050216069A1 (en) * 2001-11-29 2005-09-29 Biocontrol Medical Ltd. Pelvic disorder treatment device
US20050049648A1 (en) * 2001-11-29 2005-03-03 Biocontrol Medical Ltd. Pelvic disorder treatment device
US6862480B2 (en) 2001-11-29 2005-03-01 Biocontrol Medical Ltd. Pelvic disorder treatment device
US6712772B2 (en) 2001-11-29 2004-03-30 Biocontrol Medical Ltd. Low power consumption implantable pressure sensor
US7613516B2 (en) 2001-11-29 2009-11-03 Ams Research Corporation Pelvic disorder treatment device
US20090036946A1 (en) * 2001-11-29 2009-02-05 American Medical Systems, Inc. Pelvic disorder treatments
WO2003057313A1 (en) * 2002-01-02 2003-07-17 Ardent Pharmaceuticals, Inc. Method for screening therapeutic agents for modulation of ejaculatory response
GB2404339A (en) * 2003-07-31 2005-02-02 Catherine Taylor Pelvic floor stimulation device
US20050107848A1 (en) * 2003-11-13 2005-05-19 Physiomed Elektromedizin Ag Apparatus for electrotherapy
US7343203B2 (en) * 2003-11-13 2008-03-11 Physiomed Elektromedizin Ag Apparatus for electrotherapy
WO2007059989A2 (en) * 2005-11-24 2007-05-31 Femeda Limited Self contained device with treatment cycle for electrostimulation
US9358383B2 (en) 2005-11-24 2016-06-07 Femeda Limited Self contained device with treatment cycle for electrostimulation
US9526903B2 (en) 2005-11-24 2016-12-27 Femeda Limited Compressible device
US9381345B2 (en) 2005-11-24 2016-07-05 Femeda Limited Compressible electrodes
US9042987B2 (en) 2005-11-24 2015-05-26 Femeda Limited Compressible device
US8805509B2 (en) 2005-11-24 2014-08-12 Femeda Limited Compressible electrodes
US20090222060A1 (en) * 2005-11-24 2009-09-03 Femeda Ltd Self contained device with treatment cycle for electrostimulation
US20090228067A1 (en) * 2005-11-24 2009-09-10 Femeda Ltd Compressible device
US20090228064A1 (en) * 2005-11-24 2009-09-10 Femeda Ltd Compressible electrodes
US8509900B2 (en) 2005-11-24 2013-08-13 Femeda Limited Compressible device
WO2007059989A3 (en) * 2005-11-24 2007-11-22 Femeda Ltd Self contained device with treatment cycle for electrostimulation
US9889298B2 (en) 2006-03-03 2018-02-13 Astora Women's Health, Llc Electrode sling for treating stress and urge incontinence
US20090043356A1 (en) * 2006-03-03 2009-02-12 Ams Research Corporation Electrode Sling for Treating Stress and Urge Incontinence
US8195296B2 (en) 2006-03-03 2012-06-05 Ams Research Corporation Apparatus for treating stress and urge incontinence
US20070260288A1 (en) * 2006-03-03 2007-11-08 Yossi Gross Apparatus for treating stress and urge incontinence
US20090157091A1 (en) * 2006-04-04 2009-06-18 Ams Research Corporation Apparatus for Implanting Neural Stimulation Leads
US20070265675A1 (en) * 2006-05-09 2007-11-15 Ams Research Corporation Testing Efficacy of Therapeutic Mechanical or Electrical Nerve or Muscle Stimulation
US9656067B2 (en) 2006-05-23 2017-05-23 Publiekrechtelijke Rechtspersoon Academisch Ziekenhuis Leiden H.O.D.N. Leids Universitair Medisch Centrum Medical probe for electro-stimulation and training of pelvic floor musculature
US8983627B2 (en) * 2006-05-23 2015-03-17 Publiekrechtelijke Rechtspersoon Academisch Ziekenhuis Leiden H.O.D.N. Leids Universitair Medisch Centrum Medical probe for electro-stimulation and bio-feedback training of pelvic floor musculature
US20090270963A1 (en) * 2006-05-23 2009-10-29 Publiekrechtelijke Rechtspersoon Academisch Ziekenhuis Leiden H.O.D.N. Leids Universitair Medi Medical probe
US20100076254A1 (en) * 2006-06-05 2010-03-25 Ams Research Corporation Electrical muscle stimulation to treat fecal incontinence and/or pelvic prolapse
FR2902346A1 (en) * 2006-06-20 2007-12-21 Jean Luc Gonfard Neuromuscular system`s electrical stimulation device for female reproductive system, has electrodes fixed on support whose shape is adapted to anatomic cavity, where support has alveolus situated at specific place of area to be stimulated
US20080009914A1 (en) * 2006-07-10 2008-01-10 Ams Research Corporation Systems and Methods for Implanting Tissue Stimulation Electrodes in the Pelvic Region
US20090012592A1 (en) * 2006-07-10 2009-01-08 Ams Research Corporation Tissue anchor
US8160710B2 (en) 2006-07-10 2012-04-17 Ams Research Corporation Systems and methods for implanting tissue stimulation electrodes in the pelvic region
US20100049289A1 (en) * 2007-07-10 2010-02-25 Ams Research Corporation Tissue anchor
US9427573B2 (en) 2007-07-10 2016-08-30 Astora Women's Health, Llc Deployable electrode lead anchor
US8774942B2 (en) 2007-07-10 2014-07-08 Ams Research Corporation Tissue anchor
US20100217340A1 (en) * 2009-02-23 2010-08-26 Ams Research Corporation Implantable Medical Device Connector System
US9539433B1 (en) 2009-03-18 2017-01-10 Astora Women's Health, Llc Electrode implantation in a pelvic floor muscular structure
US20110082524A1 (en) * 2009-10-05 2011-04-07 Arp Manufacturing Llc Electro-Therapeutic Stimulator
US9302102B2 (en) 2009-10-05 2016-04-05 Arp Manufacturing Llc Electro-therapeutic stimulator
US9526892B2 (en) 2009-10-05 2016-12-27 ARP Wave LLC Electro-therapeutic stimulation
US8768474B1 (en) 2009-10-05 2014-07-01 ARP Wave LLC Electro-therapeutic stimulation
US20110160793A1 (en) * 2009-12-31 2011-06-30 Ams Research Corporation Multi-Zone Stimulation Implant System and Method
US8380312B2 (en) 2009-12-31 2013-02-19 Ams Research Corporation Multi-zone stimulation implant system and method
US9211211B2 (en) 2010-02-02 2015-12-15 Neil Luke Maurette Female posterior wall prosthesis
US9220887B2 (en) 2011-06-09 2015-12-29 Astora Women's Health LLC Electrode lead including a deployable tissue anchor
US9731112B2 (en) 2011-09-08 2017-08-15 Paul J. Gindele Implantable electrode assembly
US11110269B2 (en) 2014-08-19 2021-09-07 Femeda Ltd. Electrostimulation related devices and methods
US9119963B1 (en) 2014-12-11 2015-09-01 Mohammad Ali Al-Shemmeri Electric device for producing successive positive and negative electric charges
US10105531B2 (en) 2015-09-07 2018-10-23 Femeda Ltd. Device for electrostimulation
US20180050201A1 (en) * 2016-08-17 2018-02-22 Pui Ling TAM Non-invasive device and method for stimulating vulvar tissues and pelvic floor muscles for treating and improving dysfunction or disorders and probe unit used therefor
US10835745B2 (en) * 2016-08-17 2020-11-17 Pui Ling TAM Non-invasive device and method for stimulating vulvar tissues and pelvic floor muscles for treating and improving dysfunction or disorders and probe unit used therefor

Similar Documents

Publication Publication Date Title
US3640284A (en) Apparatus for electrotherapy of the pubococcygeus
US5370671A (en) Incontinence electrode apparatus
US3933147A (en) Apparatus and method for treating disorders in the region of the pubococcygeous muscle
US5411548A (en) Method of varying appropriate muscle strength of a person to alleviate urinary or fecal urgency or incontinence or vaginal or bladder spasms
US3943938A (en) Anal sphincter device and barium enema plug
JP6022710B2 (en) Biofeedback device and control method using magnetic stimulator
CN107049342B (en) Female pelvic floor function detection and treatment probe
US3800800A (en) Apparatus and method for incontinence control
Green et al. Feedback technique for deep relaxation
US3926178A (en) Apparatus for aiding the voluntary exercising of sphincter muscles
US3417743A (en) Training and diagnostic apparatus
JPS6022948B2 (en) Electric stimulation device for incontinence treatment
WO2010123907A1 (en) Bladder sensing using impedance and posture
JPH02124175A (en) Electric stimulation applying and pressure measuring method and device therefor
Brindley et al. The pressure exerted by the external sphincter of the urethra when its motor nerve fibres are stimulated electrically
AU743327B2 (en) Device for local magnetotherapy
CN210541593U (en) Female pelvic floor function detection and treatment probe
Dumoulin et al. Pelvic-floor rehabilitation, part 2: pelvic-floor reeducation with interferential currents and exercise in the treatment of genuine stress incontinence in postpartum women—a cohort study
GB1599466A (en) Testing device for determination of the optimal position of electrodes on an electrical stimulator
CN111437507B (en) Therapeutic apparatus and control method thereof
Šuhel Adjustable nonimplantable electrical stimulators for correction of urinary incontinence
GB2076293A (en) A device for developing control of sphincter-type muscles
CN213491532U (en) Pelvic floor muscle treatment equipment
CN220141664U (en) Pelvic floor muscle group positioning force measurer
CN209392588U (en) A kind of rectum electrode fixing device